|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 47/32 | (2006.01) |
| A61K 9/10 | (2006.01) | ||
| A61K 31/165 | (2006.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 1819362 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05825662.9 |
| Date of filing the European patent application | 2005-12-02 | |
| (97) | Date of publication of the European application | 2007-08-22 |
| (45) | Date of publication and mention of the grant of the patent | 2010-08-04 |
| (46) | Date of publication of the claims translation | 2010-11-25 |
| (86) | Number | PCT/US2005/043545 |
| Date | 2005-12-02 |
| (87) | Number | WO 2006/060618 |
| Date | 2006-06-08 |
| (30) | Number | Date | Country code |
| 632562 P | 2004-12-02 | US |
| (72) |
WONG, Warren, US
|
| (73) |
ALCON, INC.,
Bosch 69 P.O.Box 62, CH-6331 Hunenberg,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Išoriniai nepafenako preparatai |
| TOPICAL NEPAFENAC FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2024-11-20 | 347.00 EUR |